|
TIMM9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.085600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.052480E-02 |
| Normal-vs-Stage2 |
8.037600E-01 |
| Normal-vs-Stage3 |
3.690000E-02 |
| Normal-vs-Stage4 |
4.703500E-02 |
| Stage1-vs-Stage2 |
8.458000E-03 |
| Stage1-vs-Stage3 |
7.637000E-01 |
| Stage1-vs-Stage4 |
9.010800E-01 |
| Stage2-vs-Stage3 |
3.668000E-02 |
| Stage2-vs-Stage4 |
5.976400E-02 |
| Stage3-vs-Stage4 |
9.258000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.198900E-03 |
| Normal-vs-AfricanAmerican |
4.525000E-01 |
| Normal-vs-Asian |
9.105900E-02 |
| Caucasian-vs-AfricanAmerican |
2.393400E-01 |
| Caucasian-vs-Asian |
5.095800E-01 |
| AfricanAmerican-vs-Asian |
5.332800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.239800E-02 |
| Normal-vs-Female |
2.486500E-02 |
| Male-vs-Female |
8.197000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.126060E-02 |
| Normal-vs-Age(41-60Yrs) |
2.287600E-02 |
| Normal-vs-Age(61-80Yrs) |
3.988800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.180360E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.892000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.272000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.597400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.139780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.103000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.422200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.080800E-01 |
| Classical-VS-Follicular |
1.373880E-02 |
| Classical-VS-Other |
5.258600E-01 |
| Classical-VS-Normal |
5.677700E-03 |
| Tall-VS-Follicular |
1.819950E-02 |
| Tall-VS-Other |
3.439800E-01 |
| Tall-VS-Normal |
8.724600E-03 |
| Follicular-VS-Other |
7.584600E-01 |
| Follicular-VS-Normal |
8.782600E-01 |
| Other-VS-Normal |
6.010200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.161180E-01 |
| Normal-vs-N1 |
2.775900E-03 |
| N0-vs-N1 |
5.366000E-02 |
|
|
